The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Theraputic Drug Monitorings Market Research Report 2025

Global Theraputic Drug Monitorings Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1910496

No of Pages : 102

Ask Your Query
Synopsis
Therapeutic drug monitoring is the measurement of specific drugs at timed intervals in order to maintain a relatively constant concentration of the medication in the blood. Monitored drugs tend to have a narrow "therapeutic index," – the difference between the toxic and therapeutic doses of medications. For some drugs, maintaining this steady concentration in the blood is not as simple as giving a standard dose of medication to everyone. Each person will absorb, metabolise, utilise, and eliminate drugs at different rates based upon their age, general state of health, genetic makeup, and the influence of other medications that they are taking. These factors may change over time and vary from day to day or with various disease states.
The global Theraputic Drug Monitorings market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Theraputic Drug Monitorings, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Theraputic Drug Monitorings.
Report Scope
The Theraputic Drug Monitorings market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Theraputic Drug Monitorings market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Theraputic Drug Monitorings companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche AG
Siemens Healthineers
Thermo Fisher Scientific
Beckman Coulter
Agilent Technologies
BioMérieux
Sekisui Medical
DiaSorin
Fujirebio
Grifols
Ortho-Clinical Diagnostics
Quest Diagnostics
Sysmex
Tosoh
Chromsystems
Bio-Rad
R-Biopharm AG
ALPCO
BIOHIT Healthcare
MedTox
Wieslab
ARK Diagnostics
Probe Scientific
Omnica
Segment by Type
Chemiluminescence Immunoassay (CLIA)
Fluorescence Immunoassay (FPIA)
Radioimmunoassay (RIA)
Colorimetric Immunoassay
Other Immunoassays
Segment by Application
Antiepileptic Drugs
Immunosuppressant
Antitumor Drugs
Psychotropic Drugs
Antibiotic
Antifungal
Cardiovascular Drugs
Antiasthmatic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Theraputic Drug Monitorings companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Theraputic Drug Monitorings Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemiluminescence Immunoassay (CLIA)
1.2.3 Fluorescence Immunoassay (FPIA)
1.2.4 Radioimmunoassay (RIA)
1.2.5 Colorimetric Immunoassay
1.2.6 Other Immunoassays
1.3 Market by Application
1.3.1 Global Theraputic Drug Monitorings Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Antiepileptic Drugs
1.3.3 Immunosuppressant
1.3.4 Antitumor Drugs
1.3.5 Psychotropic Drugs
1.3.6 Antibiotic
1.3.7 Antifungal
1.3.8 Cardiovascular Drugs
1.3.9 Antiasthmatic
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Theraputic Drug Monitorings Market Perspective (2019-2030)
2.2 Theraputic Drug Monitorings Growth Trends by Region
2.2.1 Global Theraputic Drug Monitorings Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Theraputic Drug Monitorings Historic Market Size by Region (2019-2024)
2.2.3 Theraputic Drug Monitorings Forecasted Market Size by Region (2025-2030)
2.3 Theraputic Drug Monitorings Market Dynamics
2.3.1 Theraputic Drug Monitorings Industry Trends
2.3.2 Theraputic Drug Monitorings Market Drivers
2.3.3 Theraputic Drug Monitorings Market Challenges
2.3.4 Theraputic Drug Monitorings Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Theraputic Drug Monitorings Players by Revenue
3.1.1 Global Top Theraputic Drug Monitorings Players by Revenue (2019-2024)
3.1.2 Global Theraputic Drug Monitorings Revenue Market Share by Players (2019-2024)
3.2 Global Theraputic Drug Monitorings Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Theraputic Drug Monitorings Revenue
3.4 Global Theraputic Drug Monitorings Market Concentration Ratio
3.4.1 Global Theraputic Drug Monitorings Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Theraputic Drug Monitorings Revenue in 2023
3.5 Theraputic Drug Monitorings Key Players Head office and Area Served
3.6 Key Players Theraputic Drug Monitorings Product Solution and Service
3.7 Date of Enter into Theraputic Drug Monitorings Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Theraputic Drug Monitorings Breakdown Data by Type
4.1 Global Theraputic Drug Monitorings Historic Market Size by Type (2019-2024)
4.2 Global Theraputic Drug Monitorings Forecasted Market Size by Type (2025-2030)
5 Theraputic Drug Monitorings Breakdown Data by Application
5.1 Global Theraputic Drug Monitorings Historic Market Size by Application (2019-2024)
5.2 Global Theraputic Drug Monitorings Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Theraputic Drug Monitorings Market Size (2019-2030)
6.2 North America Theraputic Drug Monitorings Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Theraputic Drug Monitorings Market Size by Country (2019-2024)
6.4 North America Theraputic Drug Monitorings Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Theraputic Drug Monitorings Market Size (2019-2030)
7.2 Europe Theraputic Drug Monitorings Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Theraputic Drug Monitorings Market Size by Country (2019-2024)
7.4 Europe Theraputic Drug Monitorings Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Theraputic Drug Monitorings Market Size (2019-2030)
8.2 Asia-Pacific Theraputic Drug Monitorings Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2019-2024)
8.4 Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Theraputic Drug Monitorings Market Size (2019-2030)
9.2 Latin America Theraputic Drug Monitorings Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Theraputic Drug Monitorings Market Size by Country (2019-2024)
9.4 Latin America Theraputic Drug Monitorings Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Theraputic Drug Monitorings Market Size (2019-2030)
10.2 Middle East & Africa Theraputic Drug Monitorings Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2019-2024)
10.4 Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche AG
11.1.1 Roche AG Company Detail
11.1.2 Roche AG Business Overview
11.1.3 Roche AG Theraputic Drug Monitorings Introduction
11.1.4 Roche AG Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.1.5 Roche AG Recent Development
11.2 Siemens Healthineers
11.2.1 Siemens Healthineers Company Detail
11.2.2 Siemens Healthineers Business Overview
11.2.3 Siemens Healthineers Theraputic Drug Monitorings Introduction
11.2.4 Siemens Healthineers Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.2.5 Siemens Healthineers Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Theraputic Drug Monitorings Introduction
11.3.4 Thermo Fisher Scientific Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Theraputic Drug Monitorings Introduction
11.4.4 Beckman Coulter Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.4.5 Beckman Coulter Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Detail
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Theraputic Drug Monitorings Introduction
11.5.4 Agilent Technologies Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.5.5 Agilent Technologies Recent Development
11.6 BioMérieux
11.6.1 BioMérieux Company Detail
11.6.2 BioMérieux Business Overview
11.6.3 BioMérieux Theraputic Drug Monitorings Introduction
11.6.4 BioMérieux Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.6.5 BioMérieux Recent Development
11.7 Sekisui Medical
11.7.1 Sekisui Medical Company Detail
11.7.2 Sekisui Medical Business Overview
11.7.3 Sekisui Medical Theraputic Drug Monitorings Introduction
11.7.4 Sekisui Medical Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.7.5 Sekisui Medical Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Detail
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Theraputic Drug Monitorings Introduction
11.8.4 DiaSorin Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.8.5 DiaSorin Recent Development
11.9 Fujirebio
11.9.1 Fujirebio Company Detail
11.9.2 Fujirebio Business Overview
11.9.3 Fujirebio Theraputic Drug Monitorings Introduction
11.9.4 Fujirebio Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.9.5 Fujirebio Recent Development
11.10 Grifols
11.10.1 Grifols Company Detail
11.10.2 Grifols Business Overview
11.10.3 Grifols Theraputic Drug Monitorings Introduction
11.10.4 Grifols Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.10.5 Grifols Recent Development
11.11 Ortho-Clinical Diagnostics
11.11.1 Ortho-Clinical Diagnostics Company Detail
11.11.2 Ortho-Clinical Diagnostics Business Overview
11.11.3 Ortho-Clinical Diagnostics Theraputic Drug Monitorings Introduction
11.11.4 Ortho-Clinical Diagnostics Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.11.5 Ortho-Clinical Diagnostics Recent Development
11.12 Quest Diagnostics
11.12.1 Quest Diagnostics Company Detail
11.12.2 Quest Diagnostics Business Overview
11.12.3 Quest Diagnostics Theraputic Drug Monitorings Introduction
11.12.4 Quest Diagnostics Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.12.5 Quest Diagnostics Recent Development
11.13 Sysmex
11.13.1 Sysmex Company Detail
11.13.2 Sysmex Business Overview
11.13.3 Sysmex Theraputic Drug Monitorings Introduction
11.13.4 Sysmex Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.13.5 Sysmex Recent Development
11.14 Tosoh
11.14.1 Tosoh Company Detail
11.14.2 Tosoh Business Overview
11.14.3 Tosoh Theraputic Drug Monitorings Introduction
11.14.4 Tosoh Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.14.5 Tosoh Recent Development
11.15 Chromsystems
11.15.1 Chromsystems Company Detail
11.15.2 Chromsystems Business Overview
11.15.3 Chromsystems Theraputic Drug Monitorings Introduction
11.15.4 Chromsystems Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.15.5 Chromsystems Recent Development
11.16 Bio-Rad
11.16.1 Bio-Rad Company Detail
11.16.2 Bio-Rad Business Overview
11.16.3 Bio-Rad Theraputic Drug Monitorings Introduction
11.16.4 Bio-Rad Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.16.5 Bio-Rad Recent Development
11.17 R-Biopharm AG
11.17.1 R-Biopharm AG Company Detail
11.17.2 R-Biopharm AG Business Overview
11.17.3 R-Biopharm AG Theraputic Drug Monitorings Introduction
11.17.4 R-Biopharm AG Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.17.5 R-Biopharm AG Recent Development
11.18 ALPCO
11.18.1 ALPCO Company Detail
11.18.2 ALPCO Business Overview
11.18.3 ALPCO Theraputic Drug Monitorings Introduction
11.18.4 ALPCO Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.18.5 ALPCO Recent Development
11.19 BIOHIT Healthcare
11.19.1 BIOHIT Healthcare Company Detail
11.19.2 BIOHIT Healthcare Business Overview
11.19.3 BIOHIT Healthcare Theraputic Drug Monitorings Introduction
11.19.4 BIOHIT Healthcare Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.19.5 BIOHIT Healthcare Recent Development
11.20 MedTox
11.20.1 MedTox Company Detail
11.20.2 MedTox Business Overview
11.20.3 MedTox Theraputic Drug Monitorings Introduction
11.20.4 MedTox Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.20.5 MedTox Recent Development
11.21 Wieslab
11.21.1 Wieslab Company Detail
11.21.2 Wieslab Business Overview
11.21.3 Wieslab Theraputic Drug Monitorings Introduction
11.21.4 Wieslab Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.21.5 Wieslab Recent Development
11.22 ARK Diagnostics
11.22.1 ARK Diagnostics Company Detail
11.22.2 ARK Diagnostics Business Overview
11.22.3 ARK Diagnostics Theraputic Drug Monitorings Introduction
11.22.4 ARK Diagnostics Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.22.5 ARK Diagnostics Recent Development
11.23 Probe Scientific
11.23.1 Probe Scientific Company Detail
11.23.2 Probe Scientific Business Overview
11.23.3 Probe Scientific Theraputic Drug Monitorings Introduction
11.23.4 Probe Scientific Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.23.5 Probe Scientific Recent Development
11.24 Omnica
11.24.1 Omnica Company Detail
11.24.2 Omnica Business Overview
11.24.3 Omnica Theraputic Drug Monitorings Introduction
11.24.4 Omnica Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.24.5 Omnica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock